Showing results (11-20 of 326) with videos related to

Sort By:
Pageof 33
Cannabis and Cannabinoid Research|October 27, 2021
Long-Term Frequent Cannabis Use and Related Serum Cannabinoid Levels Are Not Associated with Kidney DysfunctionUdo Bonnet, Thorsten Borda, Norbert Scherbaum, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 8, 2022
Cannabis use, abuse and dependence during the COVID-19 pandemic: a scoping reviewUdo Bonnet, Michael Specka, Patrik Roser, et al.
Deutsches Arzteblatt International|February 20, 2024
Phenibutan—an Illegal Food Supplement With Psychotropic Effects and Health RisksUdo Bonnet, Norbert Scherbaum, Andreas Schaper, et al.
Fortschritte Der Neurologie-Psychiatrie|June 8, 2026
[Intravenous Subnarcotic Ketamine Infusions for Treatment-Resistant Depression: Historical Development, Comparison with Esketamine Nasalspray, and Prospects]Udo Bonnet, Norbert Scherbaum, Georg Juckel, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|December 3, 2010
Comparison of two oral symptom-triggered pharmacological inpatient treatments of acute alcohol withdrawal: clomethiazole vs. clonazepamUdo Bonnet, Maresa Lensing, Michael Specka, et al.
Drug and Alcohol Dependence|August 24, 2015
Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification (Part II): Psychiatric complaints and their relation to delta-9-tetrahydrocannabinol and its metabolites in serumUdo Bonnet, Thorsten Borda, Norbert Scherbaum, et al.
Frontiers in Psychiatry|July 11, 2022
Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled TrialsCaroline Vuilleumier, Norbert Scherbaum, Udo Bonnet, et al.
Frontiers in Psychiatry|December 5, 2022
Differences between users' and addiction medicine experts' harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debatesUdo Bonnet, Michael Specka, Ann-Kristin Kanti, et al.
Psychiatria Danubina|June 23, 2018
On the addictive power of gabapentinoids: a mini-reviewUdo Bonnet, Emily-Lisa Richter, Katrin Isbruch, et al.
Fortschritte Der Neurologie-Psychiatrie|December 15, 2022
[Comparative Harm/Benefit Analysis of Various Psychotropic Substances from the Perspective of German Drug Users and Addiction Medicine Experts - A Contribution to Psychoeducation of Substance-Addicted Individuals and Restriction/Legalization Debates]Ann-Kristin Kanti, Michael Specka, Norbert Scherbaum, et al.
Pageof 33